Inhibitors of cellular signalling are cytotoxic or block the budded-to-hyphal transition in the pathogenic yeast Candida albicans

Journal of Medical Microbiology

Volumn 58, Issue 6, 2009, Pages 779-790

  Toenjes, Kurt A ^a,b   Stark, Benjamin C ^a   Brooks, Krista M ^a   Johnson, Douglas I ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b MONTANA STATE UNIVERSITY BILLINGS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 CHLORO 1 NAPHTHALENESULFONYL)HEXAHYDRO 1H 1,4 DIAZEPINE; 1 (5 IODO 1 NAPHTHALENESULFONYL)HEXAHYDRO 1H 1,4 DIAZEPINE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 5 IODOTUBERCIDIN; AG 213; ANISOMYCIN; ANTIFUNGAL AGENT; ASCOMYCIN; BEPRIDIL; CALCIMYCIN; CALYCULIN A; CERULENIN; CHELERYTHRINE; DICHLOROBENZAMIL; EDELFOSINE; GELDANAMYCIN; GLIOTOXIN; K 252A; MASTOPARAN; N,N DIMETHYLSPHINGOSINE; PHENAMIL; RAPAMYCIN; STAUROSPORINE; TAMOXIFEN; TETRANDRINE; THUJAPLICIN; TRIFLUOPERAZINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALINOMYCIN; VINPOCETINE;

APOPTOSIS; ARTICLE; BUDDING; CANDIDA ALBICANS; DRUG MECHANISM; FUNGAL CELL; FUNGUS HYPHAE; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CULTURE MEDIA; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; HYPHAE; MICROBIAL SENSITIVITY TESTS; MORPHOGENESIS; SIGNAL TRANSDUCTION; VIRULENCE;

EID: 66449119098     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.006841-0     Document Type: Article

References (100)

1. Alem, M. A. S. & Douglas, L. J. (2004). Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrob Agents Chemother 48, 41-47. (Pubitemid 38040174)
2. Alem, M. A. S. & Douglas, L. J. (2005). Prostaglandin production during growth of Candida albicans biofilms. J Med Microbiol 54, 1001-1005. (Pubitemid 41566768)
3. Arioka, M., Hirata, A., Takatsuki, A. & Yamasaki, M. (1991). Brefeldin A blocks an early stage of protein transport in Candida albicans. J Gen Microbiol 137, 1253-1262.
4. Barrington, R. E., Subler, M. A., Rands, E., Omer, C. A., Miller, P. J., Hundley, J. E., Koester, S. K., Troyer, D. A., Bearss, D. J. & other authors (1998). A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis. Mol Cell Biol 18, 85-92. (Pubitemid 28021020)
5. Bedalov, A., Gatbonton, T., Irvine, W. P., Gottschling, D. E. & Simon, J. A. (2001). Identification of a small molecule inhibitor of Sir2p. Proc Natl Acad Sci U S A 98, 15113-15118. (Pubitemid 34013978)
6. Beggs, W. H. (1993). Anti-Candida activity of the anti-cancer drug tamoxifen. Res Commun Chem Pathol Pharmacol 80, 125-128. (Pubitemid 23129824)
7. Biswas, S., Dijck, P. V. & Datta, A. (2007). Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol Mol Biol Rev 71, 348-376. (Pubitemid 46954309)
8. Brown, A. J. P. (2002). Morphogenetic signaling pathways in Candida albicans. In Candida and Candidiasis, pp. 95-106. Edited by R. A. Calderone. Washington, DC: American Society for Microbiology.
9. 2+ antagonist, 8-(N,N-diethylamino)octyl 3,4,5-trimethoxybenzoate hydrochloride in smooth and skeletal muscles. Br J Pharmacol 53, 279-285.
10. Cho, H., Ueda, M., Tamaoka, M., Hamaguchi, M., Aisaka, K., Kiso, Y., Inoue, T., Ogino, R., Tatsuoka, T. & other authors (1991). Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase. J Med Chem 34, 1503-1505.
11. 2+ release is inhibited by mitochondrial depolarization. Biochem J 347, 593-600.
12. Cotgreave, I. A., Duddy, S. K., Kass, G. E. N., Thompson, D. & Moldeus, P. (1989). Studies on the anti-inflammatory activity of ebselen: ebselen interferes with granulocyte oxidative burst by dual inhibition of NADPH oxidase and protein kinase C. Biochem Pharmacol 38, 649-656. (Pubitemid 19050105)
13. 2+ exchange of heart mitochondria by benzothiazepine CGP-37157. J Cardiovasc Pharmacol 21, 595-599.
14. Cruz, M. C., Goldstein, A. L., Blankenship, J., Del Poeta, M., Perfect, J. R., McCusker, J. H., Bennani, Y. L., Cardenas, M. E. & Heitman, J. (2001). Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR. Antimicrob Agents Chemother 45, 3162-3170. (Pubitemid 32988844)
15. Danial, N. N. & Korsmeyer, S. J. (2004). Cell death: critical control points. Cell 116, 205-219. (Pubitemid 38167313)
16. Degterev, A., Lugovsky, A., Cardone, M., Mulley, B., Wagner, G., Mitchison, T. & Yuan, J. (2001). Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-XL. Nat Cell Biol 3, 173-182. (Pubitemid 32118371)
17. Duksin, D. & Mahoney, W. C. (1982). Relationship of the structure and biological activity of the natural homologues of tunicamycin. J Biol Chem 257, 3105-3109.
18. Ereshefsky, L., Watanabe, M. D. & Tran-Johnson, T. K. (1989). Clozapine: an atypical antipsychotic agent. Clin Pharm 8, 691-709. (Pubitemid 19263882)
19. Ernst, J. F. (2000). Transcription factors in Candida albicans - environmental control of morphogenesis. Microbiology 146, 1763-1774. (Pubitemid 30639255)
20. Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition. J Cell Biol 131, 235-242.
21. Fedorova, N. D., Badger, J. H., Robson, G. D., Wortman, J. R. & Nierman, W. C. (2005). Comparative analysis of programmed cell death pathways in filamentous fungi. BMC Genomics 6, 177-191.
22. Frey, C., Narayanan, K., McMillan, K., Spack, L., Gross, S. S., Masters, B. S. & Griffith, O. W. (1994). L-Thiocitrulline. A stereospecific, heme-binding inhibitor of nitric-oxide synthases. J Biol Chem 269, 26083-26091. (Pubitemid 2155682)
23. Garvin, J. L., Simon, S. A., Cragoe, E. J. J. & Mandel, L. J. (1985). Phenamil: an irreversible inhibitor of sodium channels in the toad urinary bladder. J Membr Biol 87, 45-54. (Pubitemid 15236751)
24. 2+-transport ATPase and brain phosphodiesterase by activators and inhibitors. Biochem J 207, 541-548.
25. Grosman, N. (1991). Effects of the ether phospholipid AMG-PC on mast cells are similar to that of the ether lipid AMG but different from that of the analogue hexadecylphosphocholine. Immunopharmacology 22, 39-47.
26. Guiraud, P., Steiman, R., Campos-Takaki, G. M., Seigle-Murandi, F. & Simeon de Buochberg, M. (1994). Comparison of antibacterial and antifungal activities of lapachol and β-lapachone. Planta Med 60, 373-374.
27. Hagiwara, M., Endo, T. & Hidaka, H. (1984). Effects of vinpocetine on cyclic nucleotide metabolism in vascular smooth muscle. Biochem Pharmacol 33, 453-457. (Pubitemid 14163168)
28. Hamaguchi, T., Sudo, T. & Osada, H. (1995). RK-682, a potent inhibitor of tyrosine phosphatase, arrested the mammalian cell cycle progression at G1 phase. FEBS Lett 372, 54-58.
29. Hara, M., Akasaka, K., Akinaga, S., Okabe, M., Nakano, H., Gomez, R., Wood, D., Uh, M. & Tamanoi, F. (1993). Identification of Ras farnesyltransferase inhibitors by microbial screening. Proc Natl Acad Sci U S A 90, 2281-2285. (Pubitemid 23078610)
30. Herbert, J. M., Augereau, J. M., Gleye, J. & Maffrand, J. P. (1990). Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172, 993-999.
31. Higashijima, T., Uzu, S., Nakajima, T. & Ross, E. M. (1988). Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins). J Biol Chem 263, 6491-6494. (Pubitemid 18150028)
32. Hoberg, K. A., Cihlar, R. L. & Calderone, R. A. (1983). Inhibitory effect of cerulenin and sodium butyrate on germination of Candida albicans. Antimicrob Agents Chemother 24, 401-408.
33. Inagaki, M., Kawamoto, S., Itoh, H., Saitoh, M., Hagiwara, M., Takahashi, J. & Hidaka, H. (1986). Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors. Mol Pharmacol 29, 577-581. (Pubitemid 16064852)
34. Ishihara, H., Martin, B. L., Brautigan, D. L., Karaki, H., Ozaki, H., Kato, Y., Fusetani, N., Watabe, S., Hashimoto, K. & other authors (1989). Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem Biophys Res Commun 159, 871-877. (Pubitemid 19101063)
35. Kase, H., Iwahashi, K., Nakanishi, S., Matsuda, Y., Yamada, K., Takahashi, M., Murakata, C., Sato, A. & Kaneko, M. (1987). K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Commun 142, 436-440. (Pubitemid 17003365)
36. Kawamoto, S. & Hidaka, H. (1984). 1-(5-Isoquinolinesulfonyl)-2- methylpiperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets. Biochem Biophys Res Commun 125, 258-264. (Pubitemid 15215874)
37. Klausner, R. D., Donaldson, J. G. & Lippincott-Schwartz, J. (1992). Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol 116, 1071-1080.
38. Knaus, H. G., McManus, O. B., Lee, S. H., Schmalhofer, W. A., Garcia-Calvo, M., Helms, L. M., Sanchez, M., Giangiacomo, K., Reuben, J. P. & other authors (1994). Tremorgenic indole alkaloids potently inhibit smooth muscle high-conductance calcium-activated potassium channels. Biochemistry 33, 5819-5828. (Pubitemid 24184586)
39. Kojic, E. M. & Darouiche, R. O. (2004). Candida infections of medical devices. Clin Microbiol Rev 17, 255-267. (Pubitemid 38534029)
40. Lackey, K., Cory, M., Davis, R., Frye, S. V., Harris, P. A., Hunter, R. N., Jung, D. K., McDonald, O. B., McNutt, R. W. & other authors (2000). The discovery of potent cRaf1 kinase inhibitors. Bioorg Med Chem Lett 10, 223-226. (Pubitemid 30105376)
41. Leberer, E., Harcus, D., Dignard, D., Johnson, L., Ushinsky, S., Thomas, D. Y. & Schroppel, K. (2001). Ras links cellular morphogenesis to virulence by regulation of the MAP kinase and cAMP signalling pathways in the pathogenic fungus Candida albicans. Mol Microbiol 42, 673-687. (Pubitemid 33064478)
42. Leesnitzer, L. M., Parks, D. J., Bledsoe, R. K., Cobb, J. E., Collins, J. L., Consler, T. G., Davis, R. G., Hull-Ryde, E. A., Lenhard, J. M. & other authors (2002). Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41, 6640-6650. (Pubitemid 34547354)
43. Levitzki, A. & Gilon, C. (1991). Tyrphostins as molecular tools and potential antiproliferative drugs. Trends Pharmacol Sci 12, 171-174.
44. Liu, H., Köhler, J. & Fink, G. R. (1994). Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science 266, 1723-1726.
45. Lokey, R. S. (2003). Forward chemical genetics: progress and obstacles on the path to a new pharmacopoeia. Curr Opin Chem Biol 7, 91-96. (Pubitemid 36126498)
46. Lynch, A. S. & Robertson, G. T. (2008). Bacterial and fungal biofilm infections. Annu Rev Med 59, 415-428.
47. Madeo, F., Herker, E., Maldener, C., Wissing, S., Lächelt, S., Herlan, M., Fehr, M., Lauber, K., Sigrist, S. J. & other authors (2002). A caspase-related protease regulates apoptosis in yeast. Mol Cell 9, 911-917. (Pubitemid 34454900)
48. Maidan, M. M., De Rop, L., Serneels, J., Exler, S., Rupp, S., Tournu, H., Thevelein, J. M. & Van Dijck, P. (2005). The G protein-coupled receptor Gpr1 and the Ga protein Gpa2 act through the cAMP-protein kinase A pathway to induce morphogenesis in Candida albicans. Mol Biol Cell 16, 1971-1986. (Pubitemid 40471964)
49. Massillon, D., Stalmans, W., van de Werve, G. & Bollen, M. (1994). Identification of the glycogenic compound 5-iodotubercidin as a general protein kinase inhibitor. Biochem J 299, 123-128. (Pubitemid 24106298)
50. McCabe, M. J. J., Jiang, S. A. & Orrenius, S. (1993). Chelation of intracellular zinc triggers apoptosis in mature thymocytes. Lab Invest 69, 101-110. (Pubitemid 23222252)
51. McKenna, J. P. & Hanson, P. J. (1993). Inhibition by Ro 31-8220 of acid secretory activity induced by carbachol indicates a stimulatory role for protein kinase C in the action of muscarinic agonists on isolated rat parietal cells. Biochem Pharmacol 46, 583-588. (Pubitemid 23262949)
52. Medana, C., Ermondi, G., Fruttero, R., Di Stilo, A., Ferretti, C. & Gasco, A. (1994). Furoxans as nitric oxide donors. 4-Phenyl-3- furoxancarbonitrile: thiol-mediated nitric oxide release and biological evaluation. J Med Chem 37, 4412-4416.
53. Merritt, J. E., Armstrong, W. P., Benham, C. D., Hallam, T. J., Jacob, R., Jaxa-Chamiec, A., Leigh, B. K., McCarthy, S. A., Moores, K. E. & Rink, T. J. (1990). SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem J 271, 515-522. (Pubitemid 20344770)
54. Miwa, T., Takagi, Y., Shinozaki, M., Yun, C.-W., Schell, W. A., Perfect, J. R., Kumagai, H. & Tamaki, H. (2004). Gpr1, a putative G-protein-coupled receptor, regulates morphogenesis and hypha formation in the pathogenic fungus Candida albicans. Eukaryot Cell 3, 919-931. (Pubitemid 39098868)
55. Mülsch, A., Lückhoff, A., Pohl, U., Busse, R. & Bassenge, E. (1989). LY 83583 (6-anilino-5,8-quinolinedione) blocks nitrovasodilator- induced cyclic GMP increases and inhibition of platelet activation. Naunyn Schmiedebergs Arch Pharmacol 340, 119-125. (Pubitemid 19192832)
56. Mülsch, A., Bauersachs, J., Schäfer, A., Stasch, J. P., Kast, R. & Busse, R. (1997). Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br J Pharmacol 120, 681-689. (Pubitemid 27089418)
57. Natarajan, K., Singh, S., Burke, T. R., Grunberger, D. & Aggarwal, B. B. (1996). Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-κB. Proc Natl Acad Sci U S A 93, 9090-9095. (Pubitemid 26282023)
58. Nehil, M. T., Tamble, C. M., Combs, D. J., Kellogg, D. R. & Lokey, R. S. (2007). Uncovering genetic relationships using small molecules that selectively target yeast cell cycle mutants. Chem Biol Drug Des 69, 258-264. (Pubitemid 46663181)
59. Nierman, W. C., Pain, A., Anderson, M. J., Wortman, J. R., Kim, H. S., Arroyo, J., Berriman, M., Abe, K., Archer, D. B. & other authors (2005). Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature 438, 1151-1156. (Pubitemid 41831684)
60. Noverr, M. C., Erb-Downward, J. R. & Huffnagle, G. B. (2003). Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clin Microbiol Rev 16, 517-533. (Pubitemid 36871319)
61. Peterson, J. R. & Mitchison, T. J. (2002). Small molecules, big impact: a history of chemical inhibitors and the cytoskeleton. Chem Biol 9, 1275-1285. (Pubitemid 36010683)
62. Phan, Q. T., Belanger, P. H. & Filler, S. G. (2000). Role of hyphal formation in interactions of Candida albicans with endothelial cells. Infect Immun 68, 3485-3490. (Pubitemid 30340448)
63. Pierce, J. W., Schoenleber, R., Jesmok, G., Best, J., Moore, S. A., Collins, T. & Gerritsen, M. E. (1997). Novel inhibitors of cytokine-induced IkBa phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 272, 21096-21103. (Pubitemid 27373968)
64. Powers, J. C., Kam, C. M., Narasimhan, L., Oleksyszyn, J., Hernandez, M. A. & Ueda, T. (1989). Mechanism-based isocoumarin inhibitors for serine proteases: use of active site structure and substrate specificity in inhibitor design. J Cell Biochem 39, 33-46. (Pubitemid 19052853)
65. Pressman, B. C. (1976). Biological applications of ionophores. Annu Rev Biochem 45, 501-530.
66. Rao, G. H. (1987). Influence of calmodulin antagonist (stelazine) on agonist-induced calcium mobilization and platelet activation. Biochem Biophys Res Commun 148, 768-775. (Pubitemid 17155480)
67. Sah, D. W. & Bean, B. P. (1994). Inhibition of P-type and N-type calcium channels by dopamine receptor antagonists. Mol Pharmacol 45, 84-92. (Pubitemid 24042286)
68. Saitoh, M., Ishikawa, T., Matsushima, S., Naka, M. & Hidaka, H. (1987). Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase. J Biol Chem 262, 7796-7801.
69. Salari, H., Braquet, P. & Borgeat, P. (1984). Comparative effects of indomethacin, acetylenic acids, 15-HETE, nordihydroguaiaretic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets. Prostaglandins Leukot Med 13, 53-60. (Pubitemid 14178623)
70. Saville, S. P., Lazzell, A. L., Monteagudo, C. & Lopez-Ribot, J. L. (2003). Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2, 1053-1060. (Pubitemid 37298719)
71. Schmidt-Westhausen, A., Schiller, R. A., Pohle, H. D. & Reichart, P. A. (1991). Oral Candida and Enterobacteriaceae in HIV-1 infection: correlation with clinical candidiasis and antimycotic therapy. J Oral Pathol Med 20, 467-472.
72. Schreiber, S. L. & Crabtree, G. R. (1992). The mechanism of action of cyclosporin A and FK506. Immunol Today 13, 136-142.
73. Smith, R. J., Sam, L. M., Justen, J. M., Bundy, G. L., Bala, G. A. & Bleasdale, J. E. (1990). Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness. J Pharmacol Exp Ther 253, 688-697. (Pubitemid 20181715)
74. Sonneborn, A., Bockmuhl, D. P., Gerads,M., Kurpanek, K., Sanglard, D. & Ernst, J. F. (2000). Protein kinase A encoded by TPK2 regulates dimorphism of Candida albicans. Mol Microbiol 35, 386-396. (Pubitemid 30055235)
75. Steinbach, W. J., Reedy, J. L., Cramer, R. A., Jr, Perfect, J. R. & Heitman, J. (2007). Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nat Rev Microbiol 5, 418-430.
76. Stuehr, D. J., Fasehun, O. A., Kwon, N. S., Gross, S. S., Gonzalez, J. A., Levi, R. & Nathan, C. F. (1991). Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J 5, 98-103. (Pubitemid 21892842)
77. Sudbery, P., Gow, N. & Berman, J. (2004). The distinct morphogenetic states of Candida albicans. Trends Microbiol 12, 317-324. (Pubitemid 38829652)
78. ++ dependent protein kinase. Biochem Biophys Res Commun 135, 397-402.
79. Tanaka, T., Ohmura, T. & Hidaka, H. (1983). Calmodulin antagonists' binding sites on calmodulin. Pharmacology 26, 249-257.
80. Tanaka, T., Satoh, T., Onozawa, Y., Kohroki, J., Itoh, N., Ishidate, M. J., Muto, N. & Tanaka, K. (1999). Apoptosis during iron chelator-induced differentiation in F9 embryonal carcinoma cells. Cell Biol Int 23, 541-550. (Pubitemid 30113549)
81. Toenjes, K. A., Munsee, S. M., Ibrahim, A. S., Jeffrey, R., Edwards, J. E., Jr & Johnson, D. I. (2005). Small-molecule inhibitors of the budded-to-hyphal-form transition in the pathogenic yeast Candida albicans. Antimicrob Agents Chemother 49, 963-972. (Pubitemid 40327711)
82. Ullmann, B. D., Myers, H., Chiranand, W., Lazzell, A. L., Zhao, Q., Vega, L. A., Lopez-Ribot, J. L., Gardner, P. R. & Gustin, M. C. (2004). Inducible defense mechanism against nitric oxide in Candida albicans. Eukaryot Cell 3, 715-723. (Pubitemid 38763858)
83. Uppuluri, P., Nett, J., Heitman, J. & Andes, D. (2008). Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. Antimicrob Agents Chemother 52, 1127-1132.
84. 2+ release and collapse of the membrane potential of Trypanosoma brucei mitochondria in situ and of isolated rat liver mitochondria. J Biol Chem 268, 8564-8568.
85. Vigushin, D. M., Mirsaidi, N., Brooke, G., Sun, C., Pace, P., Inman, L., Moody, C. J. & Coombes, R. C. (2004). Gliotoxin is a dual inhibitor of farnesyltransferase and geranylgeranyltransferase I with antitumor activity against breast cancer in vivo. Med Oncol 21, 21-30. (Pubitemid 38491326)
86. Vrijsen, R., Berghe, D. A. V., Vlietinck, A. J. & Boeye, A. (1986). Lycorine: a eukaryotic termination inhibitor? J Biol Chem 261, 505-507.
87. Wallace, K. K., Reynolds, K. A., Koch, K., McArthur, H. A. I., Brown, M. S., Wax, R. G. & Moore, B. S. (1994). Biosynthetic studies of ascomycin (FK520): formation of the (1R,3R,4R)-3,4-dihydroxycyclohexanecarboxylic acid-derived moiety. J Am Chem Soc 116, 11600-11601. (Pubitemid 127657985)
88. 2+ current in isolated nerve terminals of the rat neurohypophysis. Pflugers Arch 421, 558-565.
89. Ward, G. E., Carey, K. L. & Westwood, N. J. (2002). Using small molecules to study big questions in cellular microbiology. Cell Microbiol 4, 471-482. (Pubitemid 34993746)
90. Warenda, A. J. & Konopka, J. B. (2002). Septin function in Candida albicans morphogenesis. Mol Biol Cell 13, 2732-2746.
91. Warenda, A. J., Kauffman, S., Sherrill, T. P., Becker, J. A. & Konopka, J. B. (2003). Candida albicans septin mutants are defective for invasive growth and virulence. Infect Immun 71, 4045-4051. (Pubitemid 36753732)
92. Warnock, D. W. (2007). Trends in the epidemiology of invasive fungal infections. Nippon Ishinkin Gakkai Zasshi 48, 1-12. (Pubitemid 46280129)
93. v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc Natl Acad Sci U S A 91, 8324-8328.
94. Wykle, R. L., Miller, C. H., Lewis, J. C., Schmitt, J. D., Smith, J. A., Surles, J. R., Piantadosi, C. & O'Flaherty, J. T. (1981). Stereospecific activity of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine and comparison of analogs in the degranulation of platelets and neutrophils. Biochem Biophys Res Commun 100, 1651-1658. (Pubitemid 11026063)
95. Xu, W., Leung, S., Wright, J. & Guggino, S. E. (1999). Expression of cyclic nucleotide-gated cation channels in airway epithelial cells. J Membr Biol 171, 117-126. (Pubitemid 29461509)
96. Yaish, P., Gazit, A., Gilon, C. & Levitzki, A. (1988). Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors. Science 242, 933-935. (Pubitemid 19015255)
97. Yatomi, Y., Ruan, F., Megidish, T., Toyokuni, T., Hakomori, S. & Igarashi, Y. (1996). N,N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets. Biochemistry 35, 626-633. (Pubitemid 26032716)
98. Zeller, F. P. & Spinler, S. A. (1987). Bepridil: a new long-acting calcium channel blocking agent. Drug Intell Clin Pharm 21, 487-492. (Pubitemid 17088630)
99. Zheng, B., Oishi, K., Shoji, M., Eibl, H., Berdel, W. E., Hajdu, J., Vogler, W. R. & Kuo, J. F. (1990). Inhibition of protein kinase C, (sodium plus potassium)-activated adenosine triphosphate, and sodium pump by synthetic phospholipid analogues. Cancer Res 50, 3025-3031. (Pubitemid 20170757)
100. Zinck, R., Cahill, M. A., Kracht, M., Sachsenmaier, C., Hipskind, R. A. & Nordheim, A. (1995). Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1. Mol Cell Biol 15, 4930-4938.